Aerovate Therapeutics, Inc. (AVTE)
9.80
0.00 (0.00%)
Inactive · Last trade price on Apr 28, 2025

Aerovate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
877626721288-
Upgrade
Market Cap Growth
-87.78%-87.78%-13.15%150.50%--
Upgrade
Enterprise Value
2-12492580108-
Upgrade
Last Close Price
93.802.6522.6329.3011.79-
Upgrade
PB Ratio
1.041.005.725.691.67-
Upgrade
P/TBV Ratio
1.041.005.725.691.67-
Upgrade
Debt / Equity Ratio
0.010.010.010.010.00-
Upgrade
Quick Ratio
20.5420.546.9416.6165.642.58
Upgrade
Current Ratio
20.9320.937.0416.9068.372.64
Upgrade
Return on Equity (ROE)
-74.91%-74.91%-63.95%-34.44%-26.19%-582.84%
Upgrade
Return on Assets (ROA)
-44.88%-44.88%-38.73%-21.42%-15.98%-135.03%
Upgrade
Return on Capital (ROIC)
-49.87%-49.87%-42.76%-22.12%-16.36%-191.64%
Upgrade
Earnings Yield
-63.03%-91.00%-12.06%-7.14%-7.98%-
Upgrade
FCF Yield
-91.65%-93.05%-9.09%-5.45%-9.58%-
Upgrade
Buyback Yield / Dilution
-8.55%-8.55%-7.60%-99.06%-4975.15%-0.32%
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q